169 related articles for article (PubMed ID: 12411004)
21. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat.
Juberías JR; Calonge M; Gómez S; López MI; Calvo P; Herreras JM; Alonso MJ
Curr Eye Res; 1998 Jan; 17(1):39-46. PubMed ID: 9472469
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
Zhang W; Pan Z; Zhai C
Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
[TBL] [Abstract][Full Text] [Related]
24. Prevention of high risk corneal graft rejection using cyclosporine A (CsA) incorporated into a collagen matrix.
Mahlberg K; Uusitalo RJ; Oksala O
Ocul Immunol Inflamm; 1997 Jun; 5(2):101-10. PubMed ID: 9234374
[TBL] [Abstract][Full Text] [Related]
25. [Intraocular implantation of cyclosporine A drug delivery system in the treatment of experimental uveitis].
Dong XG; Xu YM; Yuan GQ; Shi WY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2005 Jul; 41(7):636-41. PubMed ID: 16080900
[TBL] [Abstract][Full Text] [Related]
26. Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience.
Young AL; Rao SK; Cheng LL; Wong AK; Leung AT; Lam DS
Eye (Lond); 2002 May; 16(3):304-8. PubMed ID: 12032722
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P
Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496
[TBL] [Abstract][Full Text] [Related]
28. [Experimental study on the effects of rapamycin in prevention of rat corneal allograft rejection].
Dong Y; Huang YF; Wang LQ; Chen B
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):930-5. PubMed ID: 16271181
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine in collagen particles: corneal penetration and suppression of allograft rejection.
Gebhardt BM; Varnell ED; Kaufman HE
J Ocul Pharmacol Ther; 1995; 11(4):509-17. PubMed ID: 8574814
[TBL] [Abstract][Full Text] [Related]
30. A subconjunctival degradable implant for cyclosporine delivery in corneal transplant therapy.
Apel A; Oh C; Chiu R; Saville B; Cheng YL; Rootman D
Curr Eye Res; 1995 Aug; 14(8):659-67. PubMed ID: 8529401
[TBL] [Abstract][Full Text] [Related]
31. The effect of duration and timing of systemic cyclosporine therapy on corneal allograft survival in a rat model.
Claerhout I; Beele H; Verstraete A; Van den Broecke C; Kestelyn P
Graefes Arch Clin Exp Ophthalmol; 2001 Feb; 239(2):152-7. PubMed ID: 11372546
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats.
Vallelado AI; López MI; Calonge M; Sánchez A; Alonso MJ
Curr Eye Res; 2002 Jan; 24(1):39-45. PubMed ID: 12187493
[TBL] [Abstract][Full Text] [Related]
33. Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye.
Milani JK; Pleyer U; Dukes A; Chou HJ; Lutz S; Rückert D; Schmidt KH; Mondino BJ
Ophthalmology; 1993 Jun; 100(6):890-6. PubMed ID: 8510902
[TBL] [Abstract][Full Text] [Related]
34. Intraocular dexamethasone delivery system for corneal transplantation in an animal model.
Kagaya F; Usui T; Kamiya K; Ishii Y; Tanaka S; Amano S; Oshika T
Cornea; 2002 Mar; 21(2):200-2. PubMed ID: 11862095
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporine nanomicelle eye drop: a novel medication for corneal graft transplantation treatment.
Zhang H; Wang L; Zhang L
Biol Pharm Bull; 2015; 38(6):893-900. PubMed ID: 26027830
[TBL] [Abstract][Full Text] [Related]
36. Topical cyclosporine in pediatric keratoplasty.
Cosar CB; Laibson PR; Cohen EJ; Rapuano CJ
Eye Contact Lens; 2003 Apr; 29(2):103-7. PubMed ID: 12695714
[TBL] [Abstract][Full Text] [Related]
37. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
Xi XH; Qin B; Jiang DY
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
[TBL] [Abstract][Full Text] [Related]
38. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
[TBL] [Abstract][Full Text] [Related]
39. Immunobiology of xenogeneic cornea grafts in mouse eyes. II. Immunogenicity of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes.
Tanaka K; Streilein JW
Transplantation; 2000 Feb; 69(4):616-23. PubMed ID: 10708120
[TBL] [Abstract][Full Text] [Related]
40. Systemic cyclosporine in high-risk keratoplasty: long-term results.
Hill JC
Eye (Lond); 1995; 9 ( Pt 4)():422-8. PubMed ID: 7498559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
